Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1325 studies found for:    "Chronic myeloproliferative disorders"
Show Display Options
Rank Status Study
1 Unknown  Pomalidomide in Patients With Myeloproliferative Neoplasms in Fibrotic Stage
Condition: Myeloproliferative Neoplasms
Intervention: Drug: Pomalidomide
2 Completed JAK-STAT Signalling Pathway in Familial Myeloproliferative Disorders
Condition: Myeloproliferative Disorders
Intervention: Biological: Blood samples and buccal swabs
3 Completed Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia
Intervention: Drug: PS-341
4 Recruiting A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms
Condition: Myeloproliferative Neoplasms
Intervention: Drug: SGI-110
5 Not yet recruiting Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative Disorders
Condition: Myeloproliferative Neoplasms
6 Recruiting Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms
Condition: Chronic Myeloproliferative Neoplasms
Intervention: Drug: Givinostat
7 Completed Screening for Pulmonary Vascular Changes in Patients With Chronic Myeloproliferative Diseases
Conditions: Myeloproliferative Disorders;   Pulmonary Hypertension
Intervention: Other: Echocardiography, spiroergometry, cardiac catheterization
8 Active, not recruiting Pegasys® in Patients With Myeloproliferative Diseases
Condition: Myeloproliferative Disorders
Intervention: Drug: IFN-alpha2a
9 Unknown  Tipifarnib in Treating Patients With Myeloproliferative Disorders
Conditions: Leukemia;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Drug: tipifarnib
10 Completed Role of the Circulating Procoagulants Microparticles in the Hypercoagulability of MNP Ph1-
Condition: Myeloproliferative Neoplasm
Intervention: Other: Blood sampling
11 Recruiting Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Condition: Myeloproliferative Neoplasms
Interventions: Drug: Ruxolitinib;   Drug: Decitabine
12 Recruiting Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms
Conditions: Myeloproliferative Disorders;   Pulmonary Hypertension
Intervention: Radiation: Radiology
13 Completed Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
Conditions: Polycythemia Vera;   Essential Thrombocytosis;   Idiopathic Myelofibrosis;   Neutrophils;   Chronic Myeloproliferative Disorders
14 Terminated
Has Results
Imatinib Mesylate in Treating Patients With Myelofibrosis
Condition: Chronic Myeloproliferative Disorders
Intervention: Drug: imatinib mesylate
15 Completed Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
Condition: Chronic Myeloproliferative Disorders
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cytarabine;   Drug: idarubicin;   Procedure: peripheral blood stem cell transplantation
16 Terminated Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
Conditions: Myeloproliferative Disorders;   Myeloproliferative Disorders (MPD)
17 Terminated Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic Syndromes
Interventions: Radiation: Total Body Irradiation;   Drug: Fludarabine;   Drug: Campath 1H
18 Completed Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
19 Recruiting Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015
Conditions: Acute Leukemia;   Myelodysplastic Syndromes;   Myeloproliferative Disorders
Interventions: Other: Blood sampling;   Other: Bone marrow aspirate;   Other: Skin biopsy;   Other: Buccal swab
20 Completed Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: thioguanine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.